The Full Wiki

More info on Indanylaminopropane

Indanylaminopropane: Wikis

  

Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.

Encyclopedia

From Wikipedia, the free encyclopedia

1 : 1 mixture (racemate)
Systematic (IUPAC) name
(±)-1-(2,3-dihydro-1H-inden-5-yl)propan-2-amine
Identifiers
CAS number 152624-02-7
ATC code none
PubChem 192600
Chemical data
Formula C 12H17N 
Mol. mass 175.27 g/mol
SMILES eMolecules & PubChem
Synonyms (±)-5-(2-aminopropyl)-2,3-dihydro-1H-indene;
(±)-1-(5-indanyl)-2-aminopropane;
(±)-5-(2-aminopropyl)indane;
(±)-5-indanylisopropylamine
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.  ?
Legal status Uncontrolled
Routes Oral

Indanylaminopropane (IAP), sometimes incorrectly referred to as indanylamphetamine, [1] is a psychoactive drug and research chemical of the aminoindane chemical class which has similar effects to those of the substituted methylenedioxyphenethylamine (MDxx) series of compounds. [1] It acts as a non-neurotoxic releasing agent of serotonin, norepinephrine, and dopamine,[2][3] purportedly with catecholamine equilibrium dissociation constants approximately between those of methylenedioxymethamphetamine (MDMA; "Ecstasy") and methylbenzodioxolylbutanamine (MBDB; "Eden") in comparison to serotonin. On account of its significantly greater capacity for releasing serotonin over dopamine, indanylaminopropane is considerably less reinforcing or euphoric than the mainstream MDxx compounds like MDMA; however, in combination with amphetamine, it is said to be virtually indistinguishable from methylenedioxyamphetamine (MDA) by recreational users.

See also

References

  1. ^ a b Casale JF, McKibben TD, Bozenko JS, Hays PA (2005). "Characterization of the "Indanylamphetamines"". Microgram Journal 3 (1-2): 3–10. http://www.usdoj.gov/dea/programs/forensicsci/microgram/journal_v3/mj05_v3_pg1.html.  
  2. ^ Parker MA, Marona-Lewicka D, Kurrasch D, Shulgin AT, Nichols DE (March 1998). "Synthesis and pharmacological evaluation of ring-methylated derivatives of 3,4-(methylenedioxy)amphetamine (MDA)". Journal of Medicinal Chemistry 41 (6): 1001–5. doi:10.1021/jm9705925. PMID 9526575.  
  3. ^ Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (November 1993). "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine". Journal of Medicinal Chemistry 36 (23): 3700–6. doi:10.1021/jm00075a027. PMID 8246240.  

External links








Got something to say? Make a comment.
Your name
Your email address
Message